-

Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model

Best-in-class packages are easy to access and grow with your business

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology backed by the industry’s best service and support.

Agilent Instrument Subscriptions provides customers access to the technology they need when they need it, and with the flexibility and affordability that matches their evolving scientific and financial needs.

“Instrument subscriptions offer the best of Agilent’s products and services,” said Padraig McDonnell, president of Agilent’s CrossLab Group. “Whether our customers are running large R&D projects or ramping up their lab operations, Agilent instrument subscriptions provide access to Agilent’s best-in-class solutions, allowing customers to focus on their science without worrying about limited capital budgets or financial risks.”

The program offers everything needed to run an effective operation—instruments, services, consumables, and software—together in one convenient package for a single monthly fee. Customer feedback has been positive as the attractive budget options significantly decrease any financial barrier, and the variable terms make the commitment either as short or as long as the project requires.

“Customers across industries and end-markets are increasingly seeking flexible access over direct ownership, and they need a strong partner, with the best solutions that meet their needs,” said Jacob Thaysen, president of Agilent's Life Sciences and Applied Markets Group. “This subscription program leverages Agilent’s unique capabilities and demonstrates our continued commitment to helping our customers grow their businesses.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent to Participate in 9th Annual Evercore Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in the upcoming 9th Annual Evercore Healthcare Conference. Agilent management is scheduled to participate in a fireside chat from 10 a.m. to 10:50 a.m. EST on Tuesday, Dec. 1, 2026, in Coral Gables, Florida. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website. About Agilent Technologies Agilent Technologies Inc...

Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the SureSelect Cancer Research Pan Heme, a hybrid capture-based next-generation sequencing (NGS) research solution for comprehensive genomic profiling of hematologic malignancies. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA profiling, automated sample preparation and bioinformatics in a streamlined workflow. The introduction of Su...

Agilent Completes Acquisition of Proscia

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-pathology software for clinical and life-sciences customers. Under the terms of the transaction, Agilent acquired Proscia for $240 million in cash at closing, with up to an additional $30 million payable based on the achievement of future performance milestones. Following the closing of the transact...
Back to Newsroom